Zydus Pharmaceuticals (USA) Inc recalls Mirabegron Extended-Release Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
- Products
-
- Mirabegron Extended-Release Tablets
- Where it was sold
-
Nationwide in the USA
Nationwide
- About this recall
- Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1159-3.